Piracicaba / SP - quarta-feira, 24 de abril de 2024

O que está surgindo de novo para flacidez na face e pescoço?

No Teraderm de 2012 foi apresentado uma sessão sobre flacidez facial. Entre os mestres em Laser foi discutido esse tema e o que achei muito interessante que a maioria deles acharam que  a radiofrequencia monopolar ainda ë um dos melhores resultados encontrados , citaram também outros tratamentos como o laser CO2 fracionado tanto feito com padrões mais leve em várias sessões e o Infra Vermelho  para esse tipo de tratamento. O que eles ainda estáo incerto sobre o resultado é sobre o  Ulthera® é uma nova modalidade de ultrassom micro focado possuindo efeito lifting, pois age diretamente no SMAS (Sistema Músculo Aponeurótico Superficial.), provocando retração na pele e melhorando a flacidez da face, pescoço e pálpebras, essa duvida é  porque aqui no Brasil o Ulthera é muito recente e ainda está sob observação perante os resultados.

 

Trabalho publicado -

 Ulthera®

J Cosmet Laser Ther. 2012 Dec;14(6):290-5. doi: 10.3109/14764172.2012.738912.

A intense-focused ultrasound tightening for the treatment of infraorbital laxity. Suh DH, Oh YJ, Lee SJ, Rho JH, Song KY, Kim NI, Shin MK. Source Department of Dermatology, College of Medicine, Kyung Hee University , Seoul , Korea. Abstract Abstract Background: Infraorbital laxity is a common problem that increases with age. Blepharoplasty with lipectomy is a very commonly performed surgical procedure to treat this problem; however, it is invasive and is associated with the potential for re-emergence. Therefore, young patients may prefer a non-surgical procedure rather than to a surgical procedure. Intense-focused ultrasound (IFUS) has emerged as an effective, non-surgical, tissue-tightening procedure. Objective: This study assessed the safety and efficacy of IFUS (Ulthera(TM) system, Ulthera Inc, Mesa, AZ, USA) for facial tightening in Asian patients with infraorbital laxity. Methods: We studied 15 patients who were treated with an IFUS device applied to both lower eyelids. The primary outcome measure was an objective improvement in a paired comparison of pre-treatment and post treatment (6 months) photographs. A secondary outcome measure was patient satisfaction as measured by a questionnaire. Results: The mean patient age was 50 years (range, 27-69). All patients received one to two treatments with intense-focused ultrasound. All patients in the study experienced both subjective and objective improvement. Conclusion: IFUS can be used as a non-invasive, skin-tightening procedure for infraorbital laxity. No serious, permanent, or delayed side effects were noted up to 6 months post treatment. Thus, this procedure can be effective and safe in the treatment of decreased laxity of the lower eyelids.